Recruiting Heart Disease Studies in Covington
Pelacarsen Roll-over Extension Program
This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of the double-blind parent studies (CTQJ230A1...
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with ASCVD who have elevated lipoprotein(a) (Lp...
About Heart Disease Clinical Trials in Covington
Heart disease is the leading cause of death worldwide, encompassing conditions that affect the heart and blood vessels. Coronary artery disease, the most common type, occurs when arteries supplying the heart become narrowed or blocked. Risk factors include high blood pressure, high cholesterol, diabetes, and smoking.
There are currently 2 heart disease clinical trials recruiting participants in Covington, LOUISIANA. These studies are seeking a combined 940 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Disease Clinical Trials in Covington — FAQ
Are there heart disease clinical trials in Covington?
Yes, there are 2 heart disease clinical trials currently recruiting in Covington, LOUISIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Covington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Covington research site will contact you about next steps.
Are clinical trials in Covington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Covington studies also compensate for your time and travel.
What heart disease treatments are being tested?
The 2 active trials in Covington are testing new therapies including novel drugs, biologics, and treatment approaches for heart disease.
Data updated March 2, 2026 from ClinicalTrials.gov